Despite its introduction in the 1990s, the adoption rate for VATS lobectomy remains relatively low. A group of experts met at the 2016 SCTS Annual Meeting in Birmingham, United Kingdom, to discuss the adoption, efficacy, and future of VATS lobectomy. Shanda Blackmon of the Mayo Clinic, Rochester, Minnesota, was joined by Rene Petersen of the Rigshospitalet, Copenhagen, Denmark, Eric Lim of the Royal Brompton Hospital, London, United Kingdom, and Joel Dunning of James Cook University Hospital, Middlesbrough, United Kingdom. The panelists share their experiences with the VATS lobectomy procedure and their thoughts on the importance of sub-specialization when considering the VATS approach. Dr. Lim also gives an update on the VIOLET study, an upcoming randomized clinical trial comparing the VATS approach to the traditional thoracotomy approach.
For more information on VATS lobecomy, please click here.
1.2K views on YouTube
2 Comments
As of now , there is no study which shows a survival benefit or increased local control with VATS lobectomy. Moreover with a muscle sparing thorocotomy with both the latissimus dorsi and the serratius anteroir spared through a small lateral thorocotomy the morbidity is comparable to VATS It’s not the procedure , it’s the surgeon
The VATS lobectomy is a term which describes a very diverse techniques of access and retrieval for lobectomy. Unfortunately surgeons are highly ego driven humans and in there tendency of one-upmanship with every modification, the possibility of any conclusive evidence for VATS will be a distant dream.